Mice deficient in CD38 have increased NAD+ in the brain and liver, suggesting that CD38 plays a critical role in maintaining NAD+ homeostasis 19.As a kind of NAD+-consuming enzymes, CD38 may play a specific role in the development of NAFLD. The gene discussed is CD38; the disease is metabolic dysfunction-associated steatotic liver disease.